{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T06:46:40Z","timestamp":1794466000316,"version":"4.9.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["75N93021C00015"],"award-info":[{"award-number":["75N93021C00015"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI08686"],"award-info":[{"award-number":["R01AI08686"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["75N93021C00015"],"award-info":[{"award-number":["75N93021C00015"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["75N93021C00015"],"award-info":[{"award-number":["75N93021C00015"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1038\/s41591-025-03599-6","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T06:02:44Z","timestamp":1741845764000},"page":"1454-1458","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Immune history shapes human antibody responses to H5N1 influenza viruses"],"prefix":"10.1038","volume":"31","author":[{"given":"Tyler A.","family":"Garretson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaojiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8462-6657","authenticated-orcid":false,"given":"Shuk Hang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7571-4791","authenticated-orcid":false,"given":"Gabrielle","family":"Scher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5895-4163","authenticated-orcid":false,"given":"Jefferson J. S.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos Costa","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Furey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reilly K.","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6232-8570","authenticated-orcid":false,"given":"Naiqing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6977-4168","authenticated-orcid":false,"given":"Jordan T.","family":"Ort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangchon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin A.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Eilola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7890-8815","authenticated-orcid":false,"given":"David C.","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3956-6610","authenticated-orcid":false,"given":"Sara","family":"Cherry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5298-8979","authenticated-orcid":false,"given":"Sarah","family":"Cobey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2928-7506","authenticated-orcid":false,"given":"Scott E.","family":"Hensley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"key":"3599_CR1","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1080\/22221751.2021.1872355","volume":"10","author":"NS Lewis","year":"2021","unstructured":"Lewis, N. S. et al. Emergence and spread of novel H5N8, H5N5 and H5N1 clade 2.3.4.4 highly pathogenic avian influenza in 2020. Emerg. Microbes Infect. 10, 148\u2013151 (2021).","journal-title":"Emerg. Microbes Infect."},{"key":"3599_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-13447-z","volume":"12","author":"V Caliendo","year":"2022","unstructured":"Caliendo, V. et al. Transatlantic spread of highly pathogenic avian influenza H5N1 by wild birds from Europe to North America in 2021. Sci. Rep. 12, 11729 (2022).","journal-title":"Sci. Rep."},{"key":"3599_CR3","doi-asserted-by":"publisher","first-page":"veac035","DOI":"10.1093\/ve\/veac035","volume":"8","author":"J King","year":"2022","unstructured":"King, J. et al. Highly pathogenic avian influenza virus incursions of subtype H5N8, H5N5, H5N1, H5N4, and H5N3 in Germany during 2020\u201321. Virus Evol. 8, veac035 (2022).","journal-title":"Virus Evol."},{"key":"3599_CR4","volume":"21","author":"C Adlhoch","year":"2023","unstructured":"Adlhoch, C. et al. Avian influenza overview December 2022 \u2013 March 2023. EFSA J. 21, e07917 (2023).","journal-title":"EFSA J."},{"key":"3599_CR5","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.3201\/eid2711.211281","volume":"27","author":"JM Rijks","year":"2021","unstructured":"Rijks, J. M. et al. Highly pathogenic avian influenza A(H5N1) virus in wild red foxes, the Netherlands, 2021. Emerg. Infect. Dis. 27, 2960\u20132962 (2021).","journal-title":"Emerg. Infect. Dis."},{"key":"3599_CR6","doi-asserted-by":"publisher","unstructured":"Puryear, W. et al. Outbreak of highly pathogenic avian influenza H5N1 in New England seals. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2022.07.29.501155 (2022).","DOI":"10.1101\/2022.07.29.501155"},{"key":"3599_CR7","doi-asserted-by":"publisher","first-page":"2100439","DOI":"10.2807\/1560-7917.ES.2021.26.24.2100439","volume":"26","author":"OG Pyankova","year":"2021","unstructured":"Pyankova, O. G. et al. Isolation of clade 2.3.4.4b A(H5N8), a highly pathogenic avian influenza virus, from a worker during an outbreak on a poultry farm, Russia, December 2020. Euro Surveill. 26, 2100439 (2021).","journal-title":"Euro Surveill."},{"key":"3599_CR8","doi-asserted-by":"publisher","first-page":"2300001","DOI":"10.2807\/1560-7917.ES.2023.28.3.2300001","volume":"28","author":"M Ag\u00fcero","year":"2023","unstructured":"Ag\u00fcero, M. et al. Highly pathogenic avian influenza A(H5N1) virus infection in farmed minks, Spain, October 2022. Euro Surveill. 28, 2300001 (2023).","journal-title":"Euro Surveill."},{"key":"3599_CR9","doi-asserted-by":"publisher","unstructured":"Nguyen, T. Q. et al. Emergence and interstate spread of highly pathogenic avian influenza A(H5N1) in dairy cattle. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.05.01.591751 (2024).","DOI":"10.1101\/2024.05.01.591751"},{"key":"3599_CR10","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.3201\/eid3007.240508","volume":"30","author":"ER Burrough","year":"2024","unstructured":"Burrough, E. R. et al. Highly pathogenic avian influenza A(H5N1) clade 2.3.4.4b virus infection in domestic dairy cattle and cats, United States, 2024. Emerg. Infect. Dis. 30, 1335\u20131343 (2024).","journal-title":"Emerg. Infect. Dis."},{"key":"3599_CR11","doi-asserted-by":"publisher","unstructured":"Santos, J. J. S. et al. Bovine H5N1 influenza virus binds poorly to human-type sialic acid receptors. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.08.01.606177 (2024).","DOI":"10.1101\/2024.08.01.606177"},{"key":"3599_CR12","doi-asserted-by":"publisher","unstructured":"Chopra, P. et al. Receptor binding specificity of a bovine A(H5N1) influenza virus. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.07.30.605893 (2024).","DOI":"10.1101\/2024.07.30.605893"},{"key":"3599_CR13","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41579-024-01087-1","volume":"22","author":"G Neumann","year":"2024","unstructured":"Neumann, G. & Kawaoka, Y. Highly pathogenic H5N1 avian influenza virus outbreak in cattle: the knowns and unknowns. Nat. Rev. Microbiol. 22, 525\u2013526 (2024).","journal-title":"Nat. Rev. Microbiol."},{"key":"3599_CR14","doi-asserted-by":"publisher","first-page":"4546","DOI":"10.1016\/j.cell.2024.07.024","volume":"187","author":"G Moratorio","year":"2024","unstructured":"Moratorio, G. et al. H5N1 influenza: urgent questions and directions. Cell 187, 4546\u20134548 (2024).","journal-title":"Cell"},{"key":"3599_CR15","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1093\/cid\/civ345","volume":"61","author":"Y Qin","year":"2015","unstructured":"Qin, Y. et al. Differences in the epidemiology of human cases of avian influenza A(H7N9) and A(H5N1) viruses infection. Clin. Infect. Dis. 61, 563\u2013571 (2015).","journal-title":"Clin. Infect. Dis."},{"key":"3599_CR16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0140-6736(13)61171-X","volume":"382","author":"BJ Cowling","year":"2013","unstructured":"Cowling, B. J. et al. Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: a population-based study of laboratory-confirmed cases. Lancet 382, 129\u2013137 (2013).","journal-title":"Lancet"},{"key":"3599_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41572-018-0002-y","volume":"4","author":"F Krammer","year":"2018","unstructured":"Krammer, F. et al. Influenza. Nat. Rev. Dis. Primers 4, 3 (2018).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"3599_CR18","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1126\/science.aag1322","volume":"354","author":"KM Gostic","year":"2016","unstructured":"Gostic, K. M., Ambrose, M., Worobey, M. & Lloyd-Smith, J. O. Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting. Science 354, 722\u2013726 (2016).","journal-title":"Science"},{"key":"3599_CR19","doi-asserted-by":"publisher","first-page":"e01996-15","DOI":"10.1128\/mBio.01996-15","volume":"7","author":"R Nachbagauer","year":"2016","unstructured":"Nachbagauer, R. et al. Age dependence and isotype specificity of influenza virus hemagglutinin stalk-reactive antibodies in humans. mBio 7, e01996-15 (2016).","journal-title":"mBio"},{"key":"3599_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-26538-7","volume":"8","author":"HM Yassine","year":"2018","unstructured":"Yassine, H. M. et al. Use of hemagglutinin stem probes demonstrate prevalence of broadly reactive group 1 influenza antibodies in human sera. Sci. Rep. 8, 8628 (2018).","journal-title":"Sci. Rep."},{"key":"3599_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1194073","volume":"14","author":"L Sanchez-de Prada","year":"2023","unstructured":"Sanchez-de Prada, L. et al. Group 1 and group 2 hemagglutinin stalk antibody response according to age. Front. Immunol. 14, 1194073 (2023).","journal-title":"Front. Immunol."},{"key":"3599_CR22","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/S1473-3099(11)70240-7","volume":"11","author":"JE Ledgerwood","year":"2011","unstructured":"Ledgerwood, J. E. et al. DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials. Lancet Infect. Dis. 11, 916\u2013924 (2011).","journal-title":"Lancet Infect. Dis."},{"key":"3599_CR23","doi-asserted-by":"publisher","first-page":"13133","DOI":"10.1073\/pnas.1414070111","volume":"111","author":"AH Ellebedy","year":"2014","unstructured":"Ellebedy, A. H. et al. Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans. Proc. Natl Acad. Sci. USA 111, 13133\u201313138 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3599_CR24","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1056\/NEJMoa055778","volume":"354","author":"JJ Treanor","year":"2006","unstructured":"Treanor, J. J., Campbell, J. D., Zangwill, K. M., Rowe, T. & Wolff, M. Safety and immunogenicity of an inactivated subvirion influenza A(H5N1) vaccine. N. Engl. J. Med. 354, 1343\u20131351 (2006).","journal-title":"N. Engl. J. Med."},{"key":"3599_CR25","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1038\/s41591-024-03189-y","volume":"30","author":"S Khurana","year":"2024","unstructured":"Khurana, S. et al. Licensed H5N1 vaccines generate cross-neutralizing antibodies against highly pathogenic H5N1 clade 2.3.4.4b influenza virus. Nat. Med. 30, 2771\u20132776 (2024).","journal-title":"Nat. Med."},{"key":"3599_CR26","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1172\/JCI84428","volume":"126","author":"DJ DiLillo","year":"2016","unstructured":"DiLillo, D. J., Palese, P., Wilson, P. C. & Ravetch, J. V. Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection. J. Clin. Invest. 126, 605\u2013610 (2016).","journal-title":"J. Clin. Invest."},{"key":"3599_CR27","doi-asserted-by":"publisher","first-page":"17221","DOI":"10.1073\/pnas.1920321117","volume":"117","author":"CP Arevalo","year":"2020","unstructured":"Arevalo, C. P. et al. Original antigenic sin priming of influenza virus hemagglutinin stalk antibodies. Proc. Natl Acad. Sci. USA 117, 17221\u201317227 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3599_CR28","first-page":"767","volume":"70","author":"D Hobson","year":"1972","unstructured":"Hobson, D., Curry, R. L., Beare, A. S. & Ward-Gardner, A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J. Hyg. 70, 767\u2013777 (1972).","journal-title":"J."},{"key":"3599_CR29","doi-asserted-by":"publisher","first-page":"e02134-18","DOI":"10.1128\/JVI.02134-18","volume":"93","author":"SR Christensen","year":"2019","unstructured":"Christensen, S. R. et al. Assessing the protective potential of H1N1 influenza virus hemagglutinin head and stalk antibodies in humans. J. Virol. 93, e02134-18 (2019).","journal-title":"J. Virol."},{"key":"3599_CR30","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1093\/infdis\/jiae258","volume":"230","author":"G Hoy","year":"2024","unstructured":"Hoy, G. et al. Humoral correlates of protection against influenza A\/H3N2 virus infection. J. Infect. Dis. 230, 1319\u20131328 (2024).","journal-title":"J. Infect. Dis."},{"key":"3599_CR31","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/s41591-019-0463-x","volume":"25","author":"S Ng","year":"2019","unstructured":"Ng, S. et al. Novel correlates of protection against pandemic H1N1 influenza A virus infection. Nat. Med. 25, 962\u2013967 (2019).","journal-title":"Nat. Med."},{"key":"3599_CR32","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1038\/s41591-024-03256-4","volume":"30","author":"RJ Webby","year":"2024","unstructured":"Webby, R. J. The practical longevity of stockpiled A(H5N1) influenza vaccine. Nat. Med. 30, 2729\u20132730 (2024).","journal-title":"Nat. Med."},{"key":"3599_CR33","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.1128\/JVI.03422-13","volume":"88","author":"JR Whittle","year":"2014","unstructured":"Whittle, J. R. et al. Flow cytometry reveals that H5N1 vaccination elicits cross-reactive stem-directed antibodies from multiple Ig heavy-chain lineages. J. Virol. 88, 4047\u20134057 (2014).","journal-title":"J. Virol."},{"key":"3599_CR34","doi-asserted-by":"publisher","first-page":"e02810-18","DOI":"10.1128\/mBio.02810-18","volume":"10","author":"KS Corbett","year":"2019","unstructured":"Corbett, K. S. et al. Design of nanoparticulate group 2 influenza virus hemagglutinin stem antigens that activate unmutated ancestor B cell receptors of broadly neutralizing antibody lineages. mBio 10, e02810-18 (2019).","journal-title":"mBio"},{"key":"3599_CR35","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1101\/gr.7187808","volume":"18","author":"KM Bushell","year":"2008","unstructured":"Bushell, K. M., Sollner, C., Schuster-Boeckler, B., Bateman, A. & Wright, G. J. Large-scale screening for novel low-affinity extracellular protein interactions. Genome Res. 18, 622\u2013630 (2008).","journal-title":"Genome Res."},{"key":"3599_CR36","doi-asserted-by":"publisher","first-page":"e1006271","DOI":"10.1371\/journal.ppat.1006271","volume":"13","author":"MB Doud","year":"2017","unstructured":"Doud, M. B., Hensley, S. E. & Bloom, J. D. Complete mapping of viral escape from neutralizing antibodies. PLoS Pathog. 13, e1006271 (2017).","journal-title":"PLoS Pathog."},{"key":"3599_CR37","doi-asserted-by":"publisher","first-page":"E8276","DOI":"10.1073\/pnas.1806133115","volume":"115","author":"JM Lee","year":"2018","unstructured":"Lee, J. M. et al. Deep mutational scanning of hemagglutinin helps predict evolutionary fates of human H3N2 influenza variants. Proc. Natl Acad. Sci. USA 115, E8276\u2013E8285 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3599_CR38","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1126\/science.1187816","volume":"328","author":"JD Bloom","year":"2010","unstructured":"Bloom, J. D., Gong, L. I. & Baltimore, D. Permissive secondary mutations enable the evolution of influenza oseltamivir resistance. Science 328, 1272\u20131275 (2010).","journal-title":"Science"},{"key":"3599_CR39","unstructured":"World Health Organization. Manual for the Laboratory Diagnosis and Virological Surveillance of Influenza (World Health Organization, 2011)."},{"key":"3599_CR40","doi-asserted-by":"crossref","unstructured":"Gostic, K. imprinting: Calculate birth year-specific probabilities of immune imprinting to influenza. R package version 0.1.0. GitHub cobeylab.github.io\/imprinting\/ (2022).","DOI":"10.32614\/CRAN.package.imprinting"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03599-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03599-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03599-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T10:59:49Z","timestamp":1747738789000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03599-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["3599"],"URL":"https:\/\/doi.org\/10.1038\/s41591-025-03599-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.10.31.24316514","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"assertion":[{"value":"31 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.E.H. is a co-inventor on patents that describe the use of nucleoside-modified mRNA as a vaccine platform. S.E.H. reports receiving consulting fees from Sanofi, Pfizer, Lumen, Novavax and Merck. T.A.G. was an employee of the University of Pennsylvania when the work was completed and is now an employee of GSK. The authors declare no other competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}